{"id":567157,"date":"2026-10-09T12:30:00","date_gmt":"2026-10-09T10:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=567157"},"modified":"2026-09-21T11:25:37","modified_gmt":"2026-09-21T09:25:37","slug":"un-sglt2i-la-metformine-ou-les-deux","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/un-sglt2i-la-metformine-ou-les-deux\/","title":{"rendered":"Un SGLT2i, la metformine ou les deux ?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>La metformine reste le traitement m\u00e9dicamenteux de premi\u00e8re intention en cas de diab\u00e8te de type 2 nouvellement diagnostiqu\u00e9, tandis que les inhibiteurs du cotransporteur sodium-glucose de type 2(SGLT2) sont indiqu\u00e9s en pr\u00e9sence d\u2019une maladie cardiovasculaire ou r\u00e9nale av\u00e9r\u00e9e, ou d\u2019un risque cardiovasculaire \u00e9lev\u00e9. Une \u00e9tude a \u00e9t\u00e9 men\u00e9e afin de d\u00e9terminer si un traitement pr\u00e9coce par un inhibiteur du SGLT2 modifie la fonction et la structure vasculaires chez des personnes n&#8217;ayant jamais suivi de traitement et pr\u00e9sentant un DT2 nouvellement diagnostiqu\u00e9, en comparant la dapagliflozine en monoth\u00e9rapie, la metformine en monoth\u00e9rapie et leur association.<\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fun-sglt2i-la-metformine-ou-les-deux%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>La metformine reste le traitement m\u00e9dicamenteux de premi\u00e8re intention en cas de diab\u00e8te de type 2 nouvellement diagnostiqu\u00e9, tandis que les inhibiteurs du cotransporteur sodium-glucose de type 2(SGLT2) sont indiqu\u00e9s&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fun-sglt2i-la-metformine-ou-les-deux%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":567159,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Traitement de premi\u00e8re intention du DT2","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11549,11404,11527,11531],"tags":[23395,12050,102296,33431,19600,19464,86765,80040,19432],"powerkit_post_featured":[],"class_list":["post-567157","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-endocrinologie-et-diabetologie","category-etudes","category-formation-continue","tag-dapagliflozine","tag-diabete-de-type-2","tag-epaisseur-de-la-paroi-intima-media-de-la-carotide","tag-inhibiteurs-de-sglt2-fr","tag-metformine-fr","tag-risque-cardiovasculaire","tag-sglt2i","tag-t2d-fr","tag-traitement-de-premiere-ligne","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-10-16 15:23:31","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":567049,"slug":"sglt2i-metformina-o-entrambi","post_title":"SGLT2i, metformina o entrambi?","href":"https:\/\/medizinonline.com\/it\/sglt2i-metformina-o-entrambi\/"},"pt_PT":{"locale":"pt_PT","id":567052,"slug":"sglt2i-metformina-ou-ambos","post_title":"SGLT2i, metformina ou ambos?","href":"https:\/\/medizinonline.com\/pt-pt\/sglt2i-metformina-ou-ambos\/"},"es_ES":{"locale":"es_ES","id":567060,"slug":"sglt2i-metformina-o-ambas","post_title":"\u00bfSGLT2i, metformina o ambas?","href":"https:\/\/medizinonline.com\/es\/sglt2i-metformina-o-ambas\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/567157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=567157"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/567157\/revisions"}],"predecessor-version":[{"id":568101,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/567157\/revisions\/568101"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/567159"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=567157"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=567157"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=567157"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=567157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}